Moreover, we identified CD47, an innate immune checkpoint molecule expressed on tumor cells, as the downstream molecule of SMYD3 that inhibits anti‐tumor immunity in ccRCC. Here, CD47 is linked to nonpapillary renal cell carcinoma.